I seriously think this company needs a better Market Communication officer if they have one. Those updates could be released to the markets gradually and keep every share holder in the loop rather than in one page of ann.
While those updates are informative, I will hold until they lodge FDA and by then (3 weeks) hopefully we could hear something back from CE lodgement.
Ann: Update on Australian Adult Study and FDA De Novo Submission, page-7
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)